A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product.
The report focuses on the Biologics (Biosimilar) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Biologics (Biosimilar) market.
Major Players in the Biologics (Biosimilar) market are:
Teva
Novartis
Lilly
CP Guojian Pharmacy
Merck
3sbio
Hospira
Changchun High tech
Biotech Pharma
Sandoz
Mylan
Amgen
Roche
Pfizer
Gelgen Biopharma
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
On the basis of types, the Biologics (Biosimilar) market is primarily split into:
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
On the basis of applications, the market covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Biologics (Biosimilar) Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Biologics (Biosimilar) Market Overview
1.1 Product Overview and Scope of Biologics (Biosimilar) Market
1.2 Biologics (Biosimilar) Market Segment by Type
1.2.1 Global Biologics (Biosimilar) Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Biologics (Biosimilar) Market Segment by Application
1.3.1 Biologics (Biosimilar) Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Biologics (Biosimilar) Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Biologics (Biosimilar) (2017-2029)
1.5.1 Global Biologics (Biosimilar) Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Biologics (Biosimilar) Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Biologics (Biosimilar) Industry
1.7 Impact of Carbon Neutrality on the Biologics (Biosimilar) Industry
2 Biologics (Biosimilar) Market Upstream and Downstream Analysis
2.1 Biologics (Biosimilar) Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Biologics (Biosimilar) Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Teva
3.1.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Novartis
3.2.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Lilly
3.3.1 Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.3.4 Business Overview
3.4 CP Guojian Pharmacy
3.4.1 CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Merck
3.5.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.5.4 Business Overview
3.6 3sbio
3.6.1 3sbio Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Hospira
3.7.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Changchun High tech
3.8.1 Changchun High tech Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Biotech Pharma
3.9.1 Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Sandoz
3.10.1 Sandoz Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Mylan
3.11.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Amgen
3.12.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.12.4 Business Overview
3.13 Roche
3.13.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Pfizer
3.14.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Gelgen Biopharma
3.15.1 Gelgen Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.15.4 Business Overview
3.16 AbbVie
3.16.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.16.4 Business Overview
3.17 Sanofi
3.17.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Johnson & Johnson
3.18.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.18.4 Business Overview
3.19 Novo Nordisk
3.19.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 Biologics (Biosimilar) Market Performance (2017-2022)
3.19.4 Business Overview
4 Global Biologics (Biosimilar) Market Landscape by Player
4.1 Global Biologics (Biosimilar) Sales and Share by Player (2017-2022)
4.2 Global Biologics (Biosimilar) Revenue and Market Share by Player (2017-2022)
4.3 Global Biologics (Biosimilar) Average Price by Player (2017-2022)
4.4 Global Biologics (Biosimilar) Gross Margin by Player (2017-2022)
4.5 Biologics (Biosimilar) Market Competitive Situation and Trends
4.5.1 Biologics (Biosimilar) Market Concentration Rate
4.5.2 Biologics (Biosimilar) Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Biologics (Biosimilar) Sales, Revenue, Price Trend by Type
5.1 Global Biologics (Biosimilar) Sales and Market Share by Type (2017-2022)
5.2 Global Biologics (Biosimilar) Revenue and Market Share by Type (2017-2022)
5.3 Global Biologics (Biosimilar) Price by Type (2017-2022)
5.4 Global Biologics (Biosimilar) Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Biologics (Biosimilar) Sales, Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2017-2022)
5.4.2 Global Biologics (Biosimilar) Sales, Revenue and Growth Rate of Recombinant Glycosylated Proteins (2017-2022)
6 Global Biologics (Biosimilar) Market Analysis by Application
6.1 Global Biologics (Biosimilar) Consumption and Market Share by Application (2017-2022)
6.2 Global Biologics (Biosimilar) Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biologics (Biosimilar) Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Biologics (Biosimilar) Consumption and Growth Rate of Oncology (2017-2022)
6.3.2 Global Biologics (Biosimilar) Consumption and Growth Rate of Blood Disorders (2017-2022)
6.3.3 Global Biologics (Biosimilar) Consumption and Growth Rate of Growth Hormonal Deficiency (2017-2022)
6.3.4 Global Biologics (Biosimilar) Consumption and Growth Rate of Chronic and Autoimmune Disorders (2017-2022)
6.3.5 Global Biologics (Biosimilar) Consumption and Growth Rate of Others (2017-2022)
7 Global Biologics (Biosimilar) Sales and Revenue Region Wise (2017-2022)
7.1 Global Biologics (Biosimilar) Sales and Market Share, Region Wise (2017-2022)
7.2 Global Biologics (Biosimilar) Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Biologics (Biosimilar) Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Biologics (Biosimilar) Market Forecast (2022-2029)
8.1 Global Biologics (Biosimilar) Sales, Revenue Forecast (2022-2029)
8.1.1 Global Biologics (Biosimilar) Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Biologics (Biosimilar) Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Biologics (Biosimilar) Price and Trend Forecast (2022-2029)
8.2 Global Biologics (Biosimilar) Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.3 China Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.5 India Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Biologics (Biosimilar) Sales and Revenue Forecast (2022-2029)
8.3 Global Biologics (Biosimilar) Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Non-glycosylated Proteins (2022-2029)
8.3.2 Global Biologics (Biosimilar) Revenue and Growth Rate of Recombinant Glycosylated Proteins (2022-2029)
8.4 Global Biologics (Biosimilar) Consumption Forecast by Application (2022-2029)
8.4.1 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Oncology (2022-2029)
8.4.2 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Blood Disorders (2022-2029)
8.4.3 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Growth Hormonal Deficiency (2022-2029)
8.4.4 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Chronic and Autoimmune Disorders (2022-2029)
8.4.5 Global Biologics (Biosimilar) Consumption Value and Growth Rate of Others (2022-2029)
8.5 Biologics (Biosimilar) Market Forecast Under COVID-19
9 Industry Outlook
9.1 Biologics (Biosimilar) Market Drivers Analysis
9.2 Biologics (Biosimilar) Market Restraints and Challenges
9.3 Biologics (Biosimilar) Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Biologics (Biosimilar) Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Biologics (Biosimilar) Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Biologics (Biosimilar) Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Healthcare Workforce Management System Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 86
Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics.
Workforce management provides a common set of performance-based tools and software to support corporate mana......
Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period.
The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period.
The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 117
According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period.
The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 112
According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period.
The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 108
According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period.
The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 158
According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period.
The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
